Setting new standards in information exchange for the pharmaceutical and biotech industry
Attending Companies at PODD 2012
September 24, 2012
An update on some of the companies in attendance on October 1-2nd 2012!
Ratio Drug Delivery, Allergan, Catalent Pharma Solutions, MIT, Thomas, McNerney & Partners, Astrazeneca, Hovione, Momenta Pharmaceuticals, Pfizer, Inc., Eli Lilly, MannKind Corp, University of Nebraska Medical Center, Xeris Pharma, Vertex Pharmaceuticals, Amgen, PhaseBio Pharmaceuticals Inc., FluGen Inc., Aptalis, Kala Pharmaceuticals/ Polaris Venture Partners, Locust Walk Partners, Mystic Pharmaceuticals, Inc, Novartis Institutes for Biomedical Research, Atheneos Capital Management, LLC, Global Research Services, LLC (GRS), Capsugel, Biogen Idec, Tapemark, Cubist Pharmaceuticals, Kensey Nash Corporation, Orion Pharma, EmulTech, University of Pittsburgh, Weinberg/Otomagnetics, Unigene Laboratories, Inc., Shire HGT, Skyline Ventures, ZDev Consulting, Alcyone Lifesciences Inc., Baxter, CIMA LABS, INC., F. Hoffmann-La Roche AG, Merck Research Laboratories, Novartis, Patheon, SteadyMed Therapeutics Inc, Celgene, Sanofi, Medesis Pharma, SEAlantis Ltd., Hoffmann-La Roche, Takeda Pharmaceuticals International, RPS, Otomagnetics LLC, Grace, FORMAC Pharmaceuticals, Endo, Collegium Pharmaceuticals, BD Medical, ACTUS Biotechnologies, Inc., West Pharma, University of California, Santa Barbara, STC Biologics, Polyactiva, Octoplus, PNP Smith Advisors, MicroCHIPS Inc, SR One, Path, Novo Nordisk A/S, Medtronic, SpringLeaf Therapeutics inc., Elim Pediatric Pharmaceuticals, J&J, GSK, Boehringer Ingelheim, Cerulean Pharma Inc, 3M Drug Delivery Systems Division, Tracy BioConsulting LLC, JSB Partners, BioAxone BioSciences Inc, Eisai Inc., Alnylam